Phase 1, First-in-Human Study of Futibatinib, a Highly Selective, Irreversible F
- This topic has 0 replies, 1 voice, and was last updated 3 years, 9 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Phase 1, First-in-Human Study of Futibatinib, a Highly Selective, Irreversible FGFR1-4 Inhibitor in Patients With Advanced Solid Tumors
https://pubmed.ncbi.nlm.nih.gov/32622884/
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.